Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm

@BurgerLab12 @UKCryptoKing247 @barryjohnreid21 @Alex_on_A14 @pawley_robert @MdRisette @Bebert701 @NateWeymouth @carlsmythe @ChrisJohnsonMD @IainMulady @markmcdougall13 @Pope_Bane @swedishchf @wendy_Lynnette @mcfunny @BoastIra @MRJenny8675309 @RTheatheist @

@NateWeymouth @UKCryptoKing247 @carlsmythe @ChrisJohnsonMD @IainMulady @markmcdougall13 @Pope_Bane @pawley_robert @MdRisette @BurgerLab12 @swedishchf @Alex_on_A14 @wendy_Lynnette @mcfunny @barryjohnreid21 @BoastIra @MRJenny8675309 @RTheatheist @WendyOrent

Great work by one of our consortium members; Mihály Józsi: https://t.co/F4RcuL1bAn Read how a smaller recombinant version of Factor H could be used as a therapy to reduce excessive release of pro-inflammatory molecules.